Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04568421Completed

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection

Role: lead

NCT04845997Unknown

COVID-19 Vaccination in Patients With Rheumatic Diseases

Role: lead

NCT05470569Recruiting

Argentinian Prospective Registry of Patients With Lupus

Role: lead

NCT05365009Recruiting

Registry of Autoimmune Interstitial Lung Disease

Role: collaborator

All 4 trials loaded